radiopharmaceuticals. an interview with two members of the usp expert panel on radiopharmaceuticals sheds light on what they think regulators will focus on and how you can start preparing before the final chapter is published in june . paving a new way forward the story about preparing tc- m red blood cells...
producing a lubricant from an epoxy-triglyceride promoted iron catalysts supported on pelletized carbon nanotubes for fischer-tropsch synthesis redundant floating-point fast fourier transform (fft) coprocessor room temperature processing method for preparing high efficiency, flexible peroskite solar cells...
laboratory to fight cancer. the doctor is part of the team of the clinical hospital of the ribeirão preto medical school, which performed the treatment on a patient with already severe lymphoma. considered a great success, pioneering treatment in latin america is all about removing the patient's t cells...
to treat many diseases by growing new cells to replace damaged ones. → read more national epilepsy information pool for finland epilepsy is a significant public health problem, which has implications to society that are of the same degree as those of breast or lung cancer. epilepsy is not just one disease...
forming tiny clumps in the eye. these clumps cast shadows onto the retina, and the resulting forms and shapes are referred to eye floaters. sometimes during the process of the vitreous shrinking, it remains partially attached to the retina, and tugs on it. the resulting movement of the retina's nerve cells...
colour blindness is a genetic condition caused by a difference in how one or more of the light-sensitive cells found in the retina of the eye respond to certain colours. these cells, called cones, sense wavelengths of light, and enable the retina to distinguish between colours. this difference in sensitivity...